Beta Cat Pharmaceuticals, Inc. announced it raised $1.04 Million in an initial filing from an offering of $3.04 Million
PRIVATEJul 02, 2015•about 11 years ago Amount Raised
$1.04 Million
TexasBiotechnologyHealthcareCompany
Beta Cat Pharmaceuticals, Inc.
About
Beta Cat Pharmaceuticals is a developer of beta-catenin modulators for the treatment of cancer.
Don't miss Beta Cat Pharmaceuticals, Inc.'s next move
Get an email the moment Beta Cat Pharmaceuticals, Inc. raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Beta Cat Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
